₨ NPR
NUCOXIA 90
NUCOXIA 90 contains Etoricoxib 90 mg, a selective COX-2 inhibitor designed to provide effective relief from pain and inflammation with improved gastrointestinal safety over traditional NSAIDs. It is widely used in the treatment of chronic and acute musculoskeletal conditions.
₨209.70
Ask about productDescription
NUCOXIA 90 contains Etoricoxib 90 mg, a selective COX-2 inhibitor designed to provide effective relief from pain and inflammation with improved gastrointestinal safety over traditional NSAIDs. It is widely used in the treatment of chronic and acute musculoskeletal conditions.
Composition
- Active Ingredient: Etoricoxib 90 mg
- Dosage Form: Film-coated tablet
- Route of Administration: Oral
Mechanism of Action
Etoricoxib selectively inhibits the cyclooxygenase-2 (COX-2) enzyme, reducing the synthesis of prostaglandins involved in pain, swelling, and inflammation. This selective action helps minimize gastrointestinal side effects commonly associated with non-selective NSAIDs.
Indications
NUCOXIA 90 is indicated for the treatment of:
- Osteoarthritis
- Rheumatoid arthritis
- Ankylosing spondylitis
- Chronic low back pain
- Acute pain, including post-operative and dental pain
- Dysmenorrhea (menstrual pain)
Dosage and Administration
- Usual Adult Dose: One tablet (90 mg) once daily or as prescribed
- Duration of Use: Use the lowest effective dose for the shortest possible duration
- Administration: May be taken with or without food
Storage
- Store at a temperature below 30°C
- Keep in a dry place, away from moisture and direct sunlight
- Keep out of reach of children
Precautions
- Use with caution in patients with cardiovascular conditions, hypertension, or fluid retention
- Not recommended for patients with severe liver or kidney impairment
- Avoid during pregnancy and breastfeeding unless advised by a healthcare provider
- Regular monitoring may be needed in long-term use
Reviews
There are no reviews yet.